Sponsor
Yunnan Cancer Hospital
Clinical research sponsor
Clinical trials
22 shownThe Value of Time-Dependent Diffusion MRI and Magnetic Resonance Elastography in the Precise Diagnosis and Efficacy Assessment of Breast CancerNCT07608081 · lead sponsor · 2025-10-01
RECRUITINGRapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast CancerNCT07154563 · lead sponsor · 2025-02-01
RECRUITINGApplication of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung CancerNCT06742021 · lead sponsor · 2024-11-11
RECRUITINGTumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic StatusNCT06713161 · lead sponsor · 2024-09-01
RECRUITINGPrediction of Neoadjuvant Therapy Efficacy and Prognosis for Breast Cancer Based on Multimodal DataNCT07671690 · lead sponsor · 2026-06-01
NOT_YET_RECRUITINGResearch on the Whole-Process Intelligent Diagnosis and Treatment of Digital Breast Tomosynthesis Based on Deep LearningNCT07605195 · lead sponsor · 2026-05-20
NOT_YET_RECRUITINGPerformance of Diffusion-weighted Imaging-based Virtual MR Elastography (vMRE) for Diagnosing Breast CancerNCT07608068 · lead sponsor · 2025-10-01
ACTIVE_NOT_RECRUITINGEpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast CancersNCT07018505 · lead sponsor · 2025-06-15
NOT_YET_RECRUITINGThe Application Value of Spectral CT in the Accurate Staging of Breast CancerNCT06977412 · lead sponsor · 2025-06-01
NOT_YET_RECRUITINGPrediction of Non-sentinel Lymph Node Metastatic Status of Breast Cancer Based on Pathology-MRI ImagesNCT06510738 · lead sponsor · 2024-08-01
UNKNOWNEvaluation of Axillary Lymph Node Metastasis Status of Breast Cancer Based on Pathological Images and Virtual StainingNCT06486155 · lead sponsor · 2024-08-01
UNKNOWNTrop2-targeting NIR-II Molecular Probe for Breast Cancer Precise SurgeryNCT06713681 · lead sponsor · 2024-05-13
COMPLETEDCorrelation Between Serum TK1 and Pathological Remission of Breast Cancer With Neoadjuvant ChemotherapyNCT06509555 · lead sponsor · 2024-03-01
UNKNOWNApplication of Rapid On-site Evaluation in Lymph Node Biopsy of Breast CancerNCT06495736 · lead sponsor · 2024-02-01
UNKNOWNEstablishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular ImagingNCT06715020 · collaborator · 2024-12-10
RECRUITINGPatient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap ReconstructionNCT05512286 · collaborator · 2022-08-25
RECRUITINGA Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-center, Observational StudyNCT07375979 · collaborator · 2026-02-05
NOT_YET_RECRUITINGSHR-A1811 Combine With Pyrotinib for Locally Advanced/Metastatic HER2 Positive Breast CancerNCT07132242 · collaborator · 2025-08-30
NOT_YET_RECRUITINGTGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)NCT05955391 · collaborator · 2023-01-18
ACTIVE_NOT_RECRUITINGEnsartinib in Combination With Bevacizumab in ALK-positive NSCLC Patients With TP53 MutationNCT05491811 · collaborator · 2022-08-01
ACTIVE_NOT_RECRUITINGRadiomics of Mp-MRI Assessing NAC Outcome in Breast CancerNCT03592004 · collaborator · 2018-07-18
UNKNOWNA Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.NCT02521441 · collaborator · 2014-07-03
COMPLETEDSponsor roles
lead sponsor14
collaborator8
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.